Andere Sprachen Mural Oncology plc

Aktien

A3EE4M

IE000LK2BOB4

MURA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 06.06.2024			% 5 Tage	% 1. Jan.
3,34 ^USD	0,00 %		-0,30 %	-43,58 %

04.04.	MURAL ONCOLOGY PLC : erhält Kaufen-Rating von Morgan Stanley	ZM
08.01.	Mural Oncology plc kündigt Verbesserungen bei klinischen Studien im Spätstadium an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference	05.06.
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	04.06.
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting	23.05.
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting	23.05.
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update	14.05.
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03.05.
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24.04.
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting	09.04.
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	04.04.
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update	26.03.
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update	26.03.
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting	05.03.
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting	05.03.
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	04.03.
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference	27.02.
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05.02.
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials	08.01.
Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials	08.01.
Mural Oncology plc(NasdaqGM:MURA) dropped from S&P Biotechnology Select Industry Index	18.12.
Mural Oncology plc(NasdaqGM:MURA) dropped from NASDAQ Biotechnology Index	15.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Mural Oncology plc

Aktien

A3EE4M

IE000LK2BOB4

MURA

Andere Sprachen

Filter